BioCentury
ARTICLE | Clinical News

AMG 655: Phase Ib data

May 25, 2009 7:00 AM UTC

Data from a Phase Ib trial in 13 patients showed that 3 and 10 mg/kg IV AMG 665 in combination with gemcitabine was well tolerated with no DLTs. Grade 3/4 toxicities occurred in 9 patients and were mo...